Highlights d cTag-CLIP provides a strategy to study cell-specific RNA regulation in vivo d NOVA2 controls unique RNA splicing programs in inhibitory and excitatory neurons d NOVA2 cTag-CLIP reveals a new mechanism of cell-specific AS regulation d NOVA2 regulates intron retention as a cis-acting scaffold for AS factor PTBP2 SUMMARY RNA-binding proteins (RBPs) regulate genetic diversity, but the degree to which they do so in individual cell types in vivo is unknown. We developed NOVA2 cTag-crosslinking and immunoprecipitation (CLIP) to generate functional RBP-RNA maps from different neuronal populations in the mouse brain. Combining cell type datasets from Nova2-cTag and Nova2 conditional knockout mice revealed differential NOVA2 regulatory actions on alternative splicing (AS) on the same transcripts expressed in different neurons. This includes functional differences in transcripts expressed in cortical and cerebellar excitatory versus inhibitory neurons, where we find NOVA2 is required for, respectively, development of laminar structure, motor coordination, and synapse formation. We also find that NOVA2-regulated AS is coupled to NOVA2 regulation of intron retention in hundreds of transcripts, which can sequester the trans-acting splicing factor PTBP2. In summary, cTag-CLIP complements single-cell RNA sequencing (RNA-seq) studies by providing a means for understanding RNA regulation of functional cell diversity.
In Brief cTag-CLIP provides a next-generation strategy to profile functional protein:RNA interactions at cell-specific resolution in vivo. Saito et al. show that differential NOVA2 regulatory actions on alternative splicing coupled to intron removal in different neurons.
INTRODUCTION
Alternative splicing (AS) plays spectacular roles in mammalian biology that are especially evident in the brain, where it can generate many variants from individual primary transcripts, facilitating a limited genome to act as a major driver of system complexity (Darnell, 2013; Raj and Blencowe, 2015; Zheng and Black, 2013) . The first example came from Amara and Evans (Amara et al., 1982) , who discovered that the gene for calcitonin is alternatively spliced in hypothalamic neurons to generate the neurotransmitter peptide, CGRP. Subsequently, enormous diversity was discovered in Drosophila, where stochastic AS generates mutually exclusive isoforms of Down syndrome cell adhesion molecule (DSCAM) (Schmucker et al., 2000; Zipursky and Grueber, 2013 ) that regulate appropriate axon fasciculation. Other examples of AS playing a pivotal role in mammalian brain development include developmentally regulated AS switches controlled by neuronal proteins, such as PTBP2 (Coutinho-Mansfield et al., 2007; Li et al., 2014; Licatalosi et al., 2012; Makeyev et al., 2007) , NOVA (Eom et al., 2013; Jensen et al., 2000; Ruggiu et al., 2009; Saito et al., 2016; Ule et al., 2005b; Yano et al., 2010) , RBFOX (Gehman et al., 2012; Lovci et al., 2013; Weyn-Vanhentenryck et al., 2014) , MBNL Wang et al., 2012) , nELAVL (Ince-Dunn et al., 2012) , and nSR100 (Calarco et al., 2009; Quesnel-Valliè res et al., 2015) , that govern proper early neuronal development.
An unresolved question in these studies is the extent to which such regulatory factors contribute to neuronal-type-specific identity, diversity, and function within the mammalian brain. This issue has been challenging due to methodological limitations. Current techniques of dissociation and purification of individual cell types and populations, for example, by laser capture microdissection or antibody-mediated panning methods, can produce limited numbers of cells and/or neurons, astrocytes, or microglia but missing their processes, which may account for large percentages of the net volume of such cells. Moreover, although such methods and more refined methods of microfluidic single-cell purification have been used for RNA sequencing, they have not been informative about cell-type-specific protein-RNA regulation.
We previously developed a means for studying RNA regulation termed CLIP (crosslinking and immunoprecipitation) by purifying native protein-RNA regulatory complexes from intact flashfrozen brains (Licatalosi et al., 2008; Ule et al., 2003) . Bioinformatic analysis of these data resolves RNA-protein interactions at single-nucleotide resolution (Zhang et al., 2010; Zhang and Darnell, 2011) . We recently modified CLIP using a technology termed cTag (''conditionally'' tagged)-PAPERCLIP to conditionally express AcGFP-tagged polyadenylated (poly(A))-binding protein PABPC1 in vivo in selected cell populations using Cre/Lox system (Hwang et al., 2017; Jereb et al., 2018) ; after isolation of brain, CLIP, and AcGFP purification, PAPERCLIP was able to purify and differentiate all of the poly(A) RNAs that were unique to excitatory and inhibitory neurons and distinguish these from microglia and astrocytes. This led to identification of microglia-specific poly(A) changes after inflammatory brain stimulation (lipopolysaccharide [LPS] ) (Hwang et al., 2017) that were otherwise undetectable using standard methods to purify brain microglia.
Here, we explore whether cTag-CLIP can be applied more generally for purification of a subset of RNA-protein regulatory interactions in specific neuronal types and populations and whether sensitivity is achievable with a single regulatory RNAbinding protein (RBP), particularly when binding to short-lived species, such as introns of nascent RNA. We developed cTag-CLIP for NOVA2, a neuron-specific RNA regulatory protein, together with its bound RNA targets. NOVA1 (Buckanovich and Darnell, 1997) and NOVA2 proteins have been implicated in excitatory-inhibitory neuronal balance, from their original identification as targets in paraneoplastic opsoclonus-myoclonus-ataxia (POMA), as well as studies in mice. In the latter, Nova2 haploinsufficiency leads to spontaneous epilepsy (Eom et al., 2013) , and homozygous loss of either or both NOVA isoforms leads to early postnatal death (Jensen et al., 2000) and developmental defects in acetylcholine clustering and synaptic transmission at the neuromuscular junction (NMJ) ), long-term potentiation of inhibitory postsynaptic currents (Huang et al., 2005) , neuronal migration , and axonal guidance .
In this study, we harnessed cTag technology to examine highresolution maps of NOVA2-RNA interactions in vivo with neuronal cell-type-and population-specific resolution. Integrating data from NOVA2 cTag-CLIP with RNA sequencing (RNA-seq) in Nova2-conditional knockout (Nova2-cKO) mice in different neuronal types and populations led us to distinguish NOVA2 properties and functions on the same transcripts in different cellular contexts. These unique binding profiles have functional consequences: NOVA2 acts as an essential factor specifically for development of laminar structure in cortical excitatory, but not inhibitory, neurons and for proper motor coordination and synapse formation in cerebellar Purkinje, respectively. Exploring these findings further led to the discovery of a mechanism by which NOVA2 action leads to different outcomes in different cells on the same transcripts: NOVA2 acts as a cisacting AS element to prevent intron retention (IR), and these RNA elements can serve as scaffolds to alter the binding and actions of another trans-acting AS factor, PTBP2. The cTag CLIP platform provides a general strategy for studying RNA regulation in single cell types and populations, complementing ongoing RNA-seq studies in single cells and thereby developing insight into how RBPs mediate RNA diversity and functional complexity in complex organs, such as the brain.
RESULTS

AS and RBPs Expression Diversity across CNS Regions and Neuronal Types
To first evaluate spatial and temporal AS diversity across the CNS, we re-analyzed publicly available RNA-seq datasets of multiple CNS regions and developmental stages using the Quantas pipeline Yan et al., 2015) . Over 3,000 cassette-type AS events could be identified as showing significant differences (jDexon inclusion ratej [jDIj] R 0.1; Ule et al., 2005b ; false discovery rate [FDR] < 0.05) during mouse cortical development and among different adult CNS regions (cerebral cortex, cerebellum, and spinal cord), including over 1,800 AS events in the neonatal cortex and midbrain, hindbrain, and cerebellum (Figures 1A, S1A, and S1B). AS events regulated by neural-enriched splicing factors, including NOVA, nSR100, PTBP2, MBNL, and RBFOX proteins, were determined by re-analyzing published RNA-seq datasets of each RBP-KO mouse. The total number of AS events changed in each RBP-KO mouse brain is shown in Figure S1C and Table S1 . This analysis revealed that NOVA2 was the top ranked splicing regulator contributing to spatial and temporal AS diversity across CNS regions ( Figure 1A ).
Neurons and glia, the main cell types in the brain, use different sets of AS exons . It is unclear, however, the extent to which AS diversity exists among individual neuronal subtypes or what might govern such regulation. As a baseline for demarcating neuronal-type regulatory factors that might govern cell-specific AS events, single-cell suspensions prepared from embryonic day 18.5 (E18.5) cortex of tdTomato reporter mice (Control tdTomato ) crossed with Gad2-Cre (inhibitory neuron lineage) or Emx1-Cre (cortical excitatory neuron lineage) driver mouse (Control tdTomato,Gad2-Cre or Control tdTomato,Emx1-Cre , respectively) were subjected to fluorescence-activated cell sorting (FACS) and RNA-seq analysis ( Figure 1B ). Cre-dependent tdTomato expression was confirmed by immunofluorescence staining for tdTomato ( Figure S1D ). As anticipated, GABAergic inhibitory neuronal markers (e.g., Gad1, Gad2, and Lhx6) and glutamatergic excitatory neuronal markers (e.g., Tbr1 and Slc17a7) were significantly enriched in inhibitory neuronal lineage and excitatory neuronal lineage, respectively ( Figure 1B) . RNA levels of genes encoding AS regulators in each neuronal population were then assessed and found to be non-uniform, such that Nova1, Mbnl1, Elavl2, Elavl4, and Celf4 were significantly enriched in inhibitory neuronal lineage and Nova2, Rbfox1, Rbfox3, Celf2, and Celf6 tended to be enriched in excitatory neuronal lineage ( Figure S1E ), although these demarcations were relative, not absolute. The comparison of exon inclusion rate between inhibitory and excitatory neuronal lineage identified 1,236 significant AS changes (FDR < 0.05; jDIj R 0.1; Figures 1B and S1F; Table S1), over two hundred of which overlapped with the NOVA2 target AS events ( Figures 1B and S1C) . As a quality control, we assessed the rate of contamination of non-neuronal cells in mouse E18.5 cortex and found it to be less than 4.4% ( Figure S1G ) and found no significant overlap with differentially regulated astrocyte-type AS events in the Emx1-Cre lineage ( Figure S1H ), no enrichment of glia markers in both Gad2-and Emx1-Cre lineage samples ( Figure S1I ), and enrichment of inhibitory and excitatory neuron markers in Gad2-and Emx1-Cre lineage samples, respectively. These datasets clearly demonstrate that contamination of non-neuronal cells to both Gad2-and Emx1-Cre lineage samples is slight and that cortical inhibitory and excitatory neurons express different exons. Taken together, these data suggest that, just as neuronal-enriched trans-acting splicing regulators show diverse expression patterns across CNS regions and neuronal types ( Figure 1C ), AS diversity across CNS regions and neuronal cell types may be generated by the expression and action of individual trans-acting splicing factors, such as NOVA2.
Discovery of Cell-type-Specific AS Regulation with NOVA2 cTag-CLIP NOVA was the first RBP whose in vivo RNA-binding map was generated with CLIP (Ule et al., 2003) and high-throughput sequencing (HITS-CLIP) (Licatalosi et al., 2008) , generating robust transcriptome-wide regulatory protein-RNA interaction maps in vivo. To generate NOVA2 CLIP maps with cell-type-specific resolution in intact CNS tissue, we generated ''Nova2-cTag'' mice that conditionally express AcGFP-tagged NOVA2 (NOVA2-AcGFP) in a Cre-dependent manner (Figures 2A and 2B) . A knockin strategy was employed, targeting the endogenous Nova2 locus, in order to maintain wild-type Nova2 RNA stoichiometry and regulation ( Figure S2A ). Nova2-cTag heterozygous and homozygous mice had no apparent phenotype.
To examine the RNA targets of AcGFP-tagged NOVA2 relative to endogenous NOVA2, we first bred Nova2-cTag mice to a near ubiquitous Cre driver mouse (CMV-Cre) in mouse neurons (Nova2-cTag CMV-Cre ). Immunoblot and immunofluorescent staining experiments on Nova2-cTag CMV-Cre demonstrated successful and complete Cre-dependent expression of NOVA2-AcGFP ( Figures 2C and S2B ) at E18.5. We then undertook a side-by-side comparison of the RNA-binding properties of native NOVA2 relative to AcGFP-tagged NOVA2. We undertook NOVA2-AcGFP HITS-CLIP (referred as NOVA2 cTag-CLIP) in the E18.5 cortex of Nova2-cTag CMV-Cre mice, using a mixture of two high-affinity monoclonal anti-GFP antibodies ( Figure 2D ). Comparison of the results from 3 biologic replicate NOVA2 cTag CMV-Cre -CLIP experiments and endogenous NOVA2 CLIP revealed NOVA2 binding to nearly identical (R = 0.99) target transcripts with extremely similar CLIP peaks (R = 0.87, respectively; Figure S2C ), including NOVA2 binding to its known YCAY motifs (Buckanovich and Darnell, 1997; Lewis et al., 1999) in CLIP peaks ( Figure S2D ). Taken together, these data indicate that AcGFP-tagged NOVA2 is not detectably altered in its RNA-binding properties in vivo.
We next applied NOVA2 cTag-CLIP to generate NOVA2-RNA interaction maps in two major neuronal types: GABAergic inhibitory and glutamatergic excitatory neuronal populations within E18.5 cortex. Nova2-cTag mice were crossed with cell-specific Cre drivers for inhibitory neurons (Nova2-cTag Gad2-Cre ) and excitatory neurons (Nova2-cTag Emx1-Cre ). GFP immunofluorescent staining on these mice showed successful Cre-dependent expression of NOVA2-AcGFP in the appropriate subsets of neurons ( Figure S2B ). Comparing the NOVA2 cTag-CLIP in inhibitory and excitatory neurons revealed significant enrichment of NOVA2 binding in a total of 923 and 791 transcripts, with 823 and 752 CLIP peaks specifically enriched to each neuronal subtype, respectively (FDR < 0.05; jlog2 fold changej R 1; Figure S2E) . These results indicate that NOVA2 cTag-CLIP is able to discriminate large differences in NOVA2-RNA-binding profiles between inhibitory and excitatory neurons. Taken together with prior cTag-PAPERCLIP studies of PABPC1 (Hwang et al., 2017; Jereb et al., 2018) , the cTag-CLIP platform provides The number indicates the significantly changed cassette-type AS event number (FDR < 0.05; jDIj R 0.1) between two tissues indicated by bidirectional arrows. Lower graph shows the AS event numbers intersecting with the AS events changing in each RNA-binding protein (RBP)-KO mouse brain (FDR < 0.05; jDIj R 0.1). (B) AS diversity between neuronal types. Schematics illustrating the strategy for AS analysis between two distinct neuronal types prepared from E18.5 cortex of tdTomato reporter mouse, which expresses tdTomato in Cre-dependent fashion (left panel). 1,236 AS events were significantly changed between two neuronal types (FDR < 0.05; jDIj R 0.1). Heatmaps show the excitatory or inhibitory neuron markers enrichment determined by RNAseq (upper right). AS event numbers intersecting with AS events changing in each RBP-KO mouse brain are shown (FDR < 0.05; jDIj R 0.1; lower right). (C) RBPs expression diversity within the CNS regions and neuronal types. NOVA2, NOVA1, and RBFOX3 or PTBP2 immunofluorescence staining images in 4-week-old mouse brain sections are shown. Scale bars, left: 1 mm; middle and right: 50 mm. See also Figure S1 and Table S1. (C) Cre-dependent NOVA2-AcGFP protein expression. Indicated mouse brain lysates were subjected to immunoblot analysis with anti-NOVA2 or anti-GFP antibody. SuperNOVA2 is a different NOVA2 isoform translated from the same gene . (D) Autoradiograph image of neuronal-lineage-specific NOVA2 cTag-CLIP. Colored box regions were subjected to CLIP library cloning steps. (E) Schematics illustrating the Nova2-cKO model providing NOVA2 depletion from selective neuronal type in vivo. (F) Schematics illustrating the strategy for AS analysis in specific neuronal type (FDR < 0.05; jDIj R 0.1; n = 3).
(legend continued on next page) broadly applicable approach to define RNA-protein interactions at cell-type resolution in vivo.
To search for NOVA2 directly mediated regulation in selective neuronal populations, we first set out to define all AS events in Nova2-cKO by RNA-seq ( Figures 2E and 2F ). Newly generated Nova2-cKO (Figures 2E and S2F) were crossed with the cellspecific Cre drivers mentioned above, and Cre-dependent NOVA2 protein depletion from a selective neuronal population at E18.5 in Nova2-cKO mice was confirmed by immunofluorescent staining on 4 mouse lines (Control tdTomato;Gad2-Cre , Nova2-cKO tdTomato;Gad2-Cre , Control tdTomato;Emx1-Cre , and Nova2-cKO tdTomato;Emx1-Cre ; Figures 2G and S2G ). tdTomatopositive cells from control or Nova2-cKO crossed with Cre-driver lines were collected by FACS before subjected to RNA-seq and subsequent AS analysis ( Figures 2F and S2H ). 1,970 or 2,682 AS events displayed NOVA2-dependent splicing patterns in inhibitory and excitatory neurons, respectively ( Figures 2F and S2H ).
NOVA2 cTag-CLIP Identifies Cell-type-Specific Functional RNA Regulation in Cortical Development
The Dab1.7bc exons were previously identified as a NOVA2dependent switch of Reelin-Dab1 signaling in cortex ; however, it was not known which neuronal cell subtype NOVA2 acted on to mediate this developmental switch. Accordingly, we used cTag CLIP to assess whether NOVA2 acted in either Emx-1-positive excitatory neurons, Gad2 positive inhibitory neurons, or another cell type. cTag-CLIP revealed that enrichment of NOVA2 bound to sites previously identified upstream of Dab1.7bc exons in standard whole-cortex CLIP in excitatory when compared with inhibitory neurons ( Figure 2H ). Moreover, this binding difference corresponded to functional changes in alternative Dab1.7bc exon splicing, which was misregulated in RNA-seq analysis of Nova2-cKO excitatory, but not inhibitory, neurons ( Figure 2H ); changes were confirmed by RT-PCR ( Figure 2I ). Stringent comparisons revealed that 3 of 53 stringently defined NOVA2 peaks on the Dab1 transcript showed significant differences between inhibitory or excitatory neuronal populations, and 1 of 3 NOVA2 peaks abutted the Dab1.7bc exon (Figure 2J); this peak was enriched in the excitatory neuronal population. As a measure of specificity, we noted that NOVA2 bound to other more distant sites within the Dab1 transcript to an equal extent in the different neuronal populations. These datasets demonstrate that NOVA2 binding to some particular positions and its actions on splicing are distinct between cortical excitatory and inhibitory neuronal populations. Future refinement of such results with cTag-CLIP will depend on evolving technology, including the analysis of Cre expression from different drivers in precise (versus mixtures of) neuronal sub-populations, and the expression level or ratio of RBPs and their target transcripts, which may vary between neuronal sub-populations.
The finding of NOVA2-specific AS regulation in excitatory neurons expressing Dab1.7bc led us to look at the developing cortex in mice specifically lacking NOVA2 in excitatory versus inhibitory cells. Nova2-cKO Emx1-Cre mice died between three and four weeks old and showed disorganized cortical and hippocampal CA1 and CA3 laminar structure ( Figures 2K and S2I) , which requires proper Reelin signaling (Caviness and Sidman, 1973) . In contrast, we found no neuronal migration or position abnormality in Nova2-cKO Gad2-Cre mice. 3-week-old Nova2-cKO Emx1-Cre mice displayed reduced thickness of CA1 stratum lacunosummoleculare (SLM) and dentate gyrus molecular layer ( Figure S2J ), and these changes were not present in Nova2-cKO Gad2-Cre mice (data not shown). We conclude that combining data from Nova2-cTag and Nova2-cKO mouse brain provides a particularly powerful means of defining functionally distinct aspects of RNA regulation in different neuronal cell types, here defining neuronal lineage selective NOVA2-mediated RNA regulation required for proper development of the neocortex and hippocampus.
NOVA2 Characterizes Cell-type-Specific Exon Skipping in Inhibitory Cerebellar Purkinje Cells NOVA2 functions in adult cerebellum have been unexplored because Nova2-KO mice die 2 or 3 weeks after birth . Here, we investigated NOVA2-mediated RNA regulatory networks in adult Purkinje cells (PCs) using combined analysis of Nova2-cTag and Nova2-cKO data. Nova2-cTag mice were bred to Cre driver lines to generate mouse lines expressing NOVA2-AcGFP in the entire cerebellum (CMV-Cre), PCs (Pcp2-Cre), or granule cells (GCs) (vGlut1-Cre), respectively (Figures 3A and S3A) . For each cTag/Cre driver line, NOVA2-AcGFP showed highly restricted and expected expression patterns in the cerebellum ( Figure S3A ). Comparison of pan-NOVA2 cTag-CLIP in 4-week-old mouse cerebellum (NOVA2 cTag CMV-Cre -CLIP) and endogenous NOVA2 CLIP revealed highly similar tag coverage per transcript and per CLIP peak (Figure S3B) , analogous to what was observed in cortex, indicating that the cTag strategy did not alter the RNA-binding properties of NOVA2 in the adult cerebellum.
Comparison of the NOVA2 cTag-CLIP results in inhibitory Purkinje and excitatory granule neurons showed remarkable differences ( Figures 3B and S3C ). Large numbers of NOVA2binding sites were significantly different in PCs versus GCs per transcript (4,840 in PCs versus 3,850 in GCs; FDR < 0.05; jlog 2 fold changej R 1; Figure S3C ) and per CLIP peaks (3,234 in (G) NOVA2 depletion from selective neuronal populations. NOVA2 (green) and tdTomato (red) immunofluorescent staining images in the E18.5 hippocampus of indicated 4 mouse lines. Scale bars, 100 mm. (H) Genome browser view of NOVA2-regulated Dab1.7bc AS difference in the different neuronal cell type. Significantly different CLIP peak between neuron types was highlighted with magenta shadow. ***p < 0.001. (I) RT-PCR confirmation of Dab1.7bc AS changes detected by RNA-seq (n = 3). ***p < 0.001. (J) NOVA2 cTag-CLIP peak enrichment normalized to RNA abundance and functional NOVA2 protein abundance. Each dot indicates an individual NOVA2 CLIP peak on Dab1 transcript; 3 of 53 peaks were significantly different between inhibitory (Gad2-cre) and excitatory (Emx1-Cre) neurons (p < 0.01; Fisher's exact test). (K) Cortical excitatory neuron-specific migration defect in Nova2-cKO mice. 3-week-old indicated mouse lines were subjected to immunostaining. Cux1, layer II-IV marker. Quantification of Cux1 (left) and tdTomato immunointensity (right) is shown (n R 4; **p < 0.01; ***p < 0.001). Scale bar, 50 mm. See also Figure S2 and Table S1 .
PCs versus 2,329 in GCs; FDR < 0.05; jlog 2 fold changej R 1; Figure 3B ). Interestingly, NOVA2 displayed higher 3 0 UTR binding (25%) in PCs relative to other neuronal types (less than 10% each; Figure 3C ). Despite these differences, NOVA2 retained its overall YCAY motif binding enrichment across all examined NOVA2 cTag-CLIP peaks (Figures S2D and S3D ). Thus, Figure 3 . NOVA2 Characterizes Purkinje-type Exon Skip (A) Schematics illustrating the overview for neuronal-type-specific NOVA2 cTag-CLIP in cerebellum. (B) The comparison of neuronal-type-specific NOVA2 cTag-CLIP between Purkinje cells (PCs) and granule cells (GCs). Scatterplot shows the correlation of read counts on CLIP peaks between NOVA2 cTag Pcp2-Cre -CLIP to NOVA2 cTag vGlut1-Cre -CLIP. Each black dot represents a comparable CLIP peak between two neuronal types. Each orange or magenta dot represents a significantly enriched CLIP peak in either NOVA2 cTag Pcp2-Cre -CLIP or cTag vGlut1-Cre -CLIP, respectively (FDR < 0.05; jlog2 FCj R 1). R, correlation coefficient. (C) Genomic distribution of NOVA2 and NOVA2 cTag-CLIP unique tags. (D) Schematics illustrating the strategy for AS analysis in PCs. (E) Transcript abundance changes upon NOVA2 depletion from PCs determined by RNA-seq. The empirical cumulative distribution function of NOVA2 targets binned by NOVA2 cTag Pcp2-Cre -CLIP peak tags is shown. (F) AS changes depending on NOVA2 depletion from PCs. Scatterplot shows the exon inclusion rate of the 4-week-old Control tdTomato; Pcp2-Cre and Nova2-cKO tdTomato; Pcp2-Cre determined by RNA-seq. Each black dot represents a comparative AS event. Each blue or lime green dot indicates the significantly changed AS event, which skipped in Nova2-cKO tdTomato; Pcp2-Cre (409 AS events) or included in Nova2-cKO tdTomato; Pcp2-Cre (194 AS events), respectively (n = 3; FDR < 0.05; jDIj R 0.1). (G) Discovery of a PC-selective NOVA2-mediated AS event. Genome browser view of around Arhgap26 AS exon 21 (NM_175164) is shown (left). A significantly different NOVA2 CLIP peak among neuron types was highlighted with purple shadow; peaks that were unchanged across all cell types are underscored with gray dotted shadow. RT-PCR confirmation of AS change detected by RNA-seq is shown (right panels; n = 3). **p < 0.01; ***p < 0.001. (H and I) GCs-type exon inclusion in PCs of Nova2-cKO. DI of (1) Control tdTomato; Pcp2-Cre PCs layer (RNA-seq), (2) wild-type PCs (TRAP), or (3) wild-type GCs (TRAP; Mellé n et al., 2012) versus Nova2-cKO tdTomato; Pcp2-Cre PCs layer (RNA-seq) is shown (H). Schematics illustrating the AS patterns switch from inhibitory PCs type to excitatory GCs type in Nova2-cKO tdTomato; Pcp2-Cre PCs are shown (I). See also Figure S3 and Table S1. NOVA2 discriminates between cognate YCAY-binding targets expressed in some of the same transcripts present in both cerebellar excitatory and inhibitory neurons.
We next investigated NOVA2-mediated regulation of RNA metabolism by comparing results with NOVA2 cTag-CLIP in individual cell types with results obtained by ''cell-specific'' RNAseq. For this analysis, we performed RNA-seq on manually dissected PC-enriched layers from acute cerebellar slices of Control tdTomato; Pcp2-Cre and Nova2-cKO tdTomato; Pcp2-Cre mice (Figures 3D and S3E ). Known PC markers (Itpr1, Grid2, Calb1, and Grm1) were significantly enriched in the dissected PC layer relative to whole cerebellar, and GCs markers (Neurod1, Slc17a7, Calb2, and Rbfox3) were significantly depleted (FDR < 0.01; Figure S3F ). Because cTag-NOVA2 binding showed PC-specific enrichment in 3 0 UTRs ( Figure 3C ), we examined potential NOVA2-dependent RNA abundance changes in Nova2-cKO tdTomato; Pcp2-Cre versus Control tdTomato; Pcp2-Cre PCs. Transcripts with PC-specific NOVA2 binding in 3 0 UTRs showed decreased levels upon NOVA2 loss, and transcripts free of NOVA2 3 0 UTR binding sites did not show any overall differences ( Figures 3E and S3G ). This suggests that NOVA2 3 0 UTR binding specifically in Purkinje neurons promotes functional differences in mRNA stability in different cerebellar cell types.
We also examined NOVA2-dependent AS changes in RNA-seq from the dissected PCs layer of Nova2 Control tdTomato;Pcp2-Cre and Nova2-cKO tdTomato;Pcp2-Cre mice and revealed a total of 603 NOVA2-dependent AS changes (Figure 3F) . By overlaying these AS events with PC-specific NOVAbinding sites defined from cerebellar and cortical NOVA2 cTag-CLIP, we identified 396 PC-specific NOVA2 target AS events ( Figure S3H ). For example, Arhgap26, the target antigen in a patient with subacute autoimmune cerebellar ataxia (Jarius et al., 2010) , harbored an exon (exon 21) that was suppressed by NOVA2 in a PC-restricted manner ( Figure 3G ; RNA-seq track). PC-specific suppression of exon 21 correlated with a PC-specific and significant NOVA2 binding enrichment to immediately upstream of the regulated exon 21 (Figures 3G, CLIP tracks, and S3I); we consider this as PC specific because no significant NOVA2 binding was evident at this site in other neuron-specific NOVA2 cTag-CLIP data and no loss of Nova2-dependent AS changes were evident in other neuronal cell types ( Figure 3G ). Dlg2 also displayed PC-specific NOVA2-dependent splicing change correlated with a PC-specific NOVA2-binding site (again, absent in neuron cTag CLIP peak and no AS change in loss of Nova2 in other neuron types) that was adjacent to the regulated AS exon (Figures S3I and S3J ). Ccdc64 and Map4 AS were significantly changed in both PC and GC, and NOVA2-binding patterns were comparative ( Figure S3K ).
We explored whether NOVA2 regulation might be involved in switching from GCs-like splicing to a unique PCs profile, based on our observation that NOVA2 mediated Arhgap26 exon 21 suppression in PCs (Control tdTomato;Pcp2-Cre ) and, in the absence of NOVA2 (Nova2-cKO tdTomato;Pcp2-Cre ), splicing switched to inclusion of exon 21 normally seen in GCs (lanes 2 and 3 or 9 in Figure 3G, right panel) . We re-analyzed publicly available translating ribosome affinity purification (TRAP) datasets of PCs and GCs with our AS analysis pipeline and identified a total of 6,163 AS events that were significantly different between PCs and GCs ( Figure S3L ; n = 4; FDR < 0.05; jDIj R 0.1). NOVA2 promoted exon skipping in 75 cassette types, and in Nova2-cKO PCs, the resulting pattern was switched to a GCs-type splicing profile ( Figures 3H and 3I) .
Taken together, these analyses demonstrate that differential NOVA2 binding generates AS diversity within specific neuronal types and helps to define a subset of specific AS pattern on the same transcripts in different cell types.
Purkinje Cell-Specific Nova2 Deficiency Leads Progressive Motor Discoordination and Cerebellar Atrophy
We used functional annotation clustering to determine gene ontology (GO) terms enriched in the NOVA2-mediated PC-type AS targets ( Figure 3H ). Synapse-related terms (synapse, presynaptic membrane, cell junction, and neuronal cell body), intracellular signal transduction term, and kinase activity term were significantly enriched ( Figure S4A ). NOVA2-dependent AS events among these terms had potentials to convert protein-protein or protein-DNA interactions or RNA stoichiometry (Figure S4B ). This prompted us to investigate the role of NOVA2 in cerebellar PC synaptic and cellular functions. Immunofluorescent microscopy of Nova2-cKO Pcp2-Cre PCs identified a marked defect in their dendritic morphology ( Figure 4A ). Nova2-cKO Pcp2-Cre mice also had noticeable cerebellar atrophy ( Figure 4B ), motor coordination defects ( Figure 4C ; Video S1), PC degeneration ( Figures 4D and S4C) , loss of synaptic layer thickness accompanied by neuritic swelling (Figures 4E, S4D , and S4E), and reduced spine density ( Figure 4F ). These results, ranging from histological to physiological, demonstrate that NOVA2 cTag reveals functions in a single neuronal cell type that are essential in aggregate for cell-type-specific neuronal morphology, activity, and survival.
NOVA2 Prevents Introns Retention Serving as cis-Acting Scaffolds for PTBP2
We showed NOVA2-mediated AS diversity among the same transcripts expressed in different neuronal types (Figures 2  and 3) , raising the question of the mechanism by which this occurs. Following multiple lines of evidence (Coutinho-Mansfield et al., 2007; Markovtsov et al., 2000; Polydorides et al., 2000; Solana et al., 2016; Venables et al., 2013; Zhang et al., 2010 Zhang et al., , 2016 suggesting functional interactions between RBPs in vivo, we hypothesized that combinatorial RBP regulation contributes to cell-type-specific AS regulation. Based on our RBP target AS analysis in Figure S1C , we found here that PTBP2, which has functional interactions with NOVA2 in vitro (Polydorides et al., 2000) , has target AS events showing the greatest intersection with NOVA2 target AS events ( Figure 5A ) and therefore was a strong candidate for such a trans-acting factor.
We studied PTBP2 binding differences in the presence or absence of NOVA2 by performing PTBP2 CLIP in the E18.5 cortex of wild-type and Nova2-KO mice ( Figure 5B) . A total 3,471,193 and 3,706,283 PTBP2 CLIP unique tags were obtained from wild-type and Nova2-KO cortices, respectively, with comparable CLIP tag genomic distributions (Figures 5B  and S5A ). PTBP2 CLIP peak heights in Nova2-KO were significantly higher in some neuronal cell type selective NOVA2 AS targets (e.g., Itpr1 exon 37-38 and Slc8a1; see below), indicating that NOVA2 absence impacts PTBP2 binding, consistent with the hypothesis that the two interact.
Interestingly, we noted that elevated PTBP2 CLIP peak heights in Nova2-KO were associated with retained introns (Figures 5C and S5G) , leading us to undertake a transcriptome-wide search of NOVA2-dependent intron retention (NOVA2-IR). This identified a total of 265 retained introns whose differences were significantly increased both in Ribo-Zero and poly(A)selected Nova2-KO RNA-seq libraries (Figures S5B and 5C) , and 93 of 265 NOVA2-IRs were around NOVA2-regulated AS exon. NOVA2 CLIP tags and peaks in wild-type mouse brain were enriched on the 5 0 and 3 0 end of NOVA2-IR, but not in the other introns within the same transcripts (Figures 5D and S5C) . No CLIP tag enrichment of several other RBPs to the 5 0 and 3 0 end of NOVA2-IR was identified ( Figure 5D ), indicating that Figure S4 and Video S1. (E) IR recruits trans-acting AS regulator PTBP2. PTBP2 CLIP tag number counted on NOVA2-regulated IR (NOVA2-IRs), which were normalized to total PTBP2 CLIP tag number of each replicate (n = 3). (F and G) AS difference in Nova2/Ptbp2-dKO, which have IR and increased PTBP2 CLIP peak. RT-PCR images (F) and the quantification results (G). (H) IR retains exon-intron junction. qPCR quantification of RNA retaining exon-intron junction is shown (n = 3; p < 0.05). (I) NOVA2 expression increases during cortical development at the protein (upper panels; western blot) and RNA (lower panel; RNA-seq) levels. (J and K) Those changes in NOVA2 levels in (I) are inversely related to a decrease of NOVA2-regulated IR (NOVA2-IRs; J) and PTBP2 binding (K) to those NOVA2-IRs (normalized to both total CLIP tag number and abundance of transcript; ***p < 0.001). (L) Cortical developmental stage-specific PTBP2 target AS coupling to the degree of NOVA2 regulated IR. Genome browser view of Dlg3 transcript is shown (left; significantly different CLIP peak was highlighted with magenta shadow). Quantification of AS (RT-PCR) and exon-junction (qPCR) of Dlg3 transcript is shown (right). n = 3; *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S5 and Table S1. NOVA2 is directly and specifically associated with IR removal, likely in conjunction with its local binding. PTBP2 CLIP tag numbers in NOVA2-IRs were significantly increased in Nova2-KO ( Figure 5E ) but were comparable in other introns or elsewhere in the same transcripts ( Figure S5D ). Overall, these results demonstrate that NOVA2 normally suppresses IR around NOVA2-regulated AS exons and that, in turn, suppresses PTBP2 binding locally in cis on those transcripts; conversely, the absence of NOVA2 allows an increase in IR and concomitant increase in PTBP2 binding on those retained introns.
We assessed whether increased PTBP2 binding to retained introns in the absence of NOVA2 had a functional impact on AS, assessing protein binding by CLIP and AS by RNA-seq in Nova2-KO and Ptbp2-KO cortex. We identified 3,415 significant AS events that changed in Nova2/Ptbp2-dKO (FDR < 0.05; jDIj R 0.1) relative to wild-type mice, and 876 of these were uniquely changed in Nova2/Ptbp2-dKO (relatively to either single KO; Figure S5E ). We observed two kinds of examples where AS events were additively or synergistically regulated by both NOVA2 and PTBP2 ( Figure S5F ), indicating that NOVA2 and PTBP2 can co-regulate the same AS events. Increased PTBP2 binding in NOVA2-IR was detected in AS events whose splicing patterns in Nova2/Ptbp2-dKO were distinct from those observed in Nova2-or Ptbp2-single KO, for example, Mcf2l, Itpr1 AS2 (exon37-38) in Figure 5C (see also Slc8a1, Agrn, and Ppp3cb in Figure S5G ). In contrast, changes in PTBP2 binding were not detected in AS events whose splicing patterns in Nova2/Ptbp2-dKO were comparable with Nova2-KO (e.g., Itpr1 AS1 [exon23] in Figure 5C ). Similarly, PTBP2 binding was significantly higher in both NOVA2 and PTBP2-dependent AS events with NOVA2-IR than the others (Figure S5H ). AS and IR differences were confirmed by RT-PCR and qPCR interrogating exon-intron junction reads, respectively ( Figures 5F-5H ). Taken together, these results suggest a functional interaction between NOVA2 and PTBP2 includes NOVA2 regulation of IR as a scaffold for PTBP2 binding with the potential to impact AS regulation.
To assess whether such regulation naturally occurs in vivo (beyond our observations in Nova2-KO mice brain), we took advantage of the observation that Nova2 protein and RNA expression gradually increases during cortical development ( Figure 5I ). This increase correlated with decrease of NOVA2-IR (Figures 5J and S5I ) and of PTBP2 binding ( Figure 5K ), which is relevant to AS regulation mediated by PTBP2 in E12.5 cortex, but not in E18.5, and to distinguishable AS pattern of Nova2/ Ptbp2-double KO from Nova2-single KO (e.g., Dlg3 exons 15-17 in Figure 5L ), indicating that IR regulation by NOVA2 contributes to alter PTBP2-mediated AS as cortical development proceeds. Taken together, these results are consistent with the suggestion that the trans-acting AS factor NOVA2 regulates IR, which acts as a cis-acting scaffolding platform for PTBP2, and thereby allows PTBP2-mediated AS regulation.
As a measure of specificity, we noted that the degree of IR within developmentally regulated AS events was significantly higher than the other introns in same transcripts ( Figure S5J ). NOVA2 independent splicing and IR in Tnk2 transcript showed AS switch and decrease of IR, of PTBP2 binding, and of PTBP2-dependent AS effect according to cortical develop-ment ( Figures S5K-S5M) . These results demonstrate that IR acts as a variable cis-acting scaffolding platform for PTBP2 across various natural conditions. NOVA2 Prevents Neuronal Cell-type-Specific IR and Diversifies AS Regulation We found that NOVA2-IR was unique for each individual neuronal type and coupled to AS change. Such differential regulation was seen in multiple transcripts, including Gphn, Itpr1, Slc8a1, and Arhgap26 (Figures 3G, 6A, and S6A ). For example, NOVA2-dependent Gphn AS2 changes were observed in Nova2-cKO Purkinje cells, but not in either cortical excitatory or inhibitory neurons ( Figures 6A and 6B) . Itpr1 AS1 was changed both in cortical excitatory neurons and Purkinje cells, but not in cortical inhibitory neurons. Separately, an occult nonsensemediated decay (NMD)-inducible exon within Itpr1 AS2 region, whose inclusion correlated with decrease of ITPR1 protein amount ( Figure S6B ), was highly included in the cortical excitatory neurons and $5% included in Purkinje cells, but not in cortical inhibitory neurons ( Figures 6A and 6B ). In each case, these neuronal cell-type-specific, NOVA2-regulated AS events were coupled to NOVA2 cTag-CLIP enrichment close to NOVA2-regulated exon and IR increases in the specific cell type (Figures 6C and 6D) . Taken together, these results reinforce the finding of diverse NOVA2 functions on the same transcripts expressed in different neuronal cell types in vivo. Moreover, they indicate one potential mechanism by which such cell type specificity is regulated: NOVA2-mediated IR removal can contribute to generate neuronal-types-specific mRNA regulatory diversity ( Figure 6E ).
DISCUSSION
In the present work, we have found that a single splicing factor mediates AS diversity across different CNS regions, within individual neuronal subtypes in those regions, and with different mechanisms. These results rely on establishment of a new high-resolution CLIP platform technology, ''cTag-CLIP,'' to generate regulatory RBP-RNA interaction maps within very small neuronal subsets to resolve their RNA regulatory profiles. For example, with NOVA2 cTag-CLIP, we were able to define hundreds of differential NOVA2 binding sites in inhibitory versus excitatory neuronal transcripts in the cortex. Moreover, we could extend the discrimination of differences mediated by the same regulatory protein and the same transcripts in different brain regions. For example, NOVA2 differentially regulates splicing of the transcript encoding the key Reelin signaling protein Dab1, with different consequences in cortical excitatory versus inhibitory neurons. As another example, we observe that NOVA2 regulates exclusion of an occult NMD exon in the Itpr1 transcript in excitatory, but not inhibitory, neurons in the cortex yet shows the opposite pattern in the cerebellum, where it regulates the same exon in inhibitory Purkinje neurons ( Figure 6A ). Itpr1 mRNA was significantly reduced only in PC-specific Nova2-cKO when compared with controls ( Figure 6D ), coincident with selective NOVA2 cTag-CLIP binding in the Itrp1 3 0 UTR of PCs ( Figures  6A and 6C ), but not in cortical excitatory and inhibitory neuron transcripts, indicating that specific NOVA2 functions in 3 0 UTR (C) NOVA2 cTag-CLIP peak enrichment normalized to RNA abundance and functional NOVA2 protein abundance. Each dot indicates an individual NOVA2 CLIP peak on either the Gphn or Itpr1 transcript (as for Figure 3I ; p < 0.01; Fisher's exact test). (D) Cell-type-selective IR retains exon-intron junction. Quantification of transcripts or its retaining exon-intron junction by qPCR is shown (n = 3; *p < 0.05). Orange, Purkinje cells; red, cortical excitatory neurons; green, cortical inhibitory neurons. (E) Model schematics for neuronal subtype-specific AS and its regulatory mechanism. NOVA2 regulates exon definition and IR, which serves as a platform for trans-acting AS regulators (left). NOVA2 cTag-CLIP revealed different NOVA2 binding positions on the same transcripts in different neuronal cell types, in which NOVA2 regulates cell-type-specific AS and promotes cell-type-specific intron removal (right). This cell-type-specific IR removal can alter other RBPs binding to intron and exon definition. See also Figure S6. of Itpr1 in Purkinje cells to regulate mRNA abundance. Hence, cTag-CLIP reveals for the first time the extent of fine-tuning of RNA regulation such that it can be tuned to differentially regulate distinct outcomes for the same transcripts in different cell types and brain regions.
We find that NOVA2 action relates to combinations of or competition to regulatory factors within the cells; unexpectedly, the titration of such factors appears to play a key role here. NOVA2 regulates removal of hundreds of retained introns, binding directly and specifically to those pre-mRNAs ( Figure 5D ). Moreover, NOVA2 cTag-CLIP reveals that NOVA2 suppresses IR uniquely in certain cell types, and as NOVA2 levels decrease, retained introns titrate binding of a second regulatory protein, PTBP2, revealing a tight and mechanistic coupling of splicing regulation with IR. We conclude that NOVA2 acts both as a trans-acting AS factor to determine exon definition and as a cis-acting AS element to regulate IR, which can serve as scaffolds to alter RBP-RNA interactions of another trans-acting splicing factor (e.g., PTBP2). Taken together, our results illustrate how cTag-CLIP combined with genetic models can provide novel insights into RNA regulation, leading us to discover a new biological function of NOVA2 in IR and an unexpected role for mechanisms by which different trans-acting factors can interact to regulate splicing in different cell types.
The discriminatory ability of cTag-CLIP in the cerebellum revealed that, although NOVA2 is expressed in both Purkinje (inhibitory) and granule (excitatory) neurons, it generates sharp differences in RNA-binding property in both cells. Dysregulation of NOVA2 functions, including cell-type-specific AS regulation, leads to functional defects in the mouse brain; Nova2-cKO in cerebellar PCs leads to Purkinje cell dendritic shrinkage, death, cerebellar atrophy, and a motor behavior defect. The PC selective NOVA2-regulated AS exon of Arhgap26 and Dlg2 codes amino acids nearby known protein domain SRC homology 3 domain (SH3) and PDZ domain, respectively, both of which are well-known domains important for protein-protein interaction. Moreover, NOVA2-regulated exons listed in Figure S5A coded amino acids, including protein phosphorylation sites (Dlg2 and Mtdh), protein-protein interaction domains or motifs (Grin1, Erc2, Nrxn1, Snph, and Plcb4), and DNA-binding domains (Smad2; Figure S5B ). This differential regulation may be important for maintaining the degree of cell-type-specific protein-protein interactions and signaling pathways required for maintaining morphology and survival of PCs. Interestingly, NOVA2-mediated AS of Grin1 alters the local architecture of heterotetrameric NMDA receptors and ion channel properties in NMDA receptors (Regan et al., 2018) , suggesting that NOVA2 involves in controlling neuron-type-specific NMDA receptor's property, although we recognize that NMDA receptors may have a relatively minor role in Purkinje neurons. Such functional discrimination is not restricted to the cerebellum, as we also find that NOVA2 regulates cell-type-specific function in cortical neurons, as evident from defects in cortical and hippocampal CA1 and CA3 laminar structure (Figures 2K, S2I , and S2J). We anticipate that NOVA2 AS regulation may be responsible for such changes, for example, by regulating protein isoforms and thereby regulating neuronal-type-specific processes, such as protein-protein interactions, which are required for the unique morphology or for the unique synaptic functions in individual neuronal type.
RNA processing diversity, including AS among different neuronal types, might be generated by the difference of RBPs expression ratio in each neuronal type, of RBPs or target RNA modification, and/or of unknown RBPs co-factor. There are clearly different expression levels of AS regulators (e.g., NOVA, RBFOX, ELAVL/Hu, and PTBP2) across the CNS areas and neuronal types ( Figure 1C ; Gehman et al., 2012; Ince-Dunn et al., 2012; Makeyev et al., 2007) . cTag CLIP in vivo cell-type-specific approaches can provide mechanisms of RBPs-mediated RNA regulation diversity, including not only AS but RNA stability, translation, and RNA modification across different neuronal types. Our observation connecting a major action of NOVA2 on IR in specific cell types and AS reflects recent studies demonstrating connections between IR and translation (Gill et al., 2017) , neuronal activity (Mauger et al., 2016) , RNA modification (Pendleton et al., 2017) , and other aspects of cellular regulation in multiple cell types (Braunschweig et al., 2014) , including cancer cells (Braun et al., 2017) . More generally, applying our in vivo cTag strategy to cell types vulnerable to disease may yield insight into how functions of these specific cell types are disorganized when RNA control is dysregulated.
Overall, our in vivo cell-type-specific approach offers novel insights into cell-specific RNA biology within intact living tissues. More generally, cTag CLIP provides a universal platform that can be extended to an array of RBPs and cell types to reveal mechanisms regulating metabolism of the same transcripts in different neuronal types to generate functional diversity.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: STAR+METHODS   KEY RESOURCES TABLE  QUANTIFICATION AND STATISTICAL ANALYSIS AS quantification RNA-seq data were aligned with OLego de-novo splicing aligner. AS were quantified using Quantas. Quantas calculates exon inclusion rate and differential exon inclusion rate between two groups (DI). Fisher exact test in Quantas was used to call FDR adjusted p values. We used FDR < 0.05 and DI > j0.1j as significant AS events.
DECLARATION OF INTERESTS
CLIP peaks enrichment CLIP peaks were called by using all unique cTag-CLIP tags , and normalized to both RNA abundance (RNA-seq reads per transcript) and functional NOVA2 amount (CLIP read number per each transcript) of each cell-type. Fold change between the different neuronal cell-type was calculated by using the normalized CLIP peak height. Fisher's exact test was used for calling p value.
For analyses that normalize CLIP data to both RNA-seq and estimated protein levels (Figures 2I, 6C, and S3I) , we took the following approach. The quantitative normalization of functional NOVA2 protein was normalized by the tag number/peak for specific sites/CLIP peaks to tag number for the entire transcript, and comparing resulted parameters in different cell types. We then re-analyzed our CLIP peak enrichment relative to normalized total CLIP tags/transcript and to mRNA abundance.
One reason to approach NOVA2 protein normalization cautiously (in addition to addressing the issue by RNA-seq and quantitative IF) is that we ideally want to normalize to total functional NOVA2 present in the entirety of each cell type. RNA-seq per cell does not, for example, discriminate between different phosphorylated isoforms of the protein (see, for example, Dredge et al., 2005) , and neither RNA-seq nor IF is able to satisfactorily (in our view) quantitate NOVA2 protein present through the cell body and the entire dendritic tree and NOVA protein is clearly present and associated with target transcripts in both locations (see, e.g., Racca et al., 2010) . Given these limitations, we believe that normalizing to total functional NOVA2 binding across transcripts provides a fair proxy with which to quantitatively estimate functional NOVA2 regulatory capacity per cell type.
DATA AND SOFTWARE AVAILABILITY
The GEO accession number for NOVA2 cTag-CLIP and RNA-seq originated from this study is GEO: GSE103316.
